MediPal (MAHLY) Stock Price, News & Analysis

Company Overview

MediPal (OTCMKTS: MAHLY) represents the American depositary receipts of Medipal Holdings Corporation, a Tokyo‐based integrated healthcare distributor. The company specializes in the procurement, warehousing and delivery of prescription pharmaceuticals, over-the-counter medicines, medical devices and nutritional supplements. Through its extensive logistics network, MediPal services a wide range of clients including retail pharmacies, drugstores, hospitals and clinics across Japan.

In addition to its core distribution activities, MediPal offers ancillary services such as in-store pharmacy management support, inventory control systems and consulting for healthcare retailers. The company’s Retail & Consumer Business segment provides consumer health products and lifestyle goods under private-label and third-party brands. MediPal’s Hospital Business unit supplies medical equipment, surgical disposables and diagnostics to healthcare institutions, while its Pharma Solutions branch manages contract logistics and regulatory compliance services for pharmaceutical manufacturers.

Beyond its domestic operations, MediPal has established a presence in key Asian markets through subsidiaries and joint ventures, facilitating cross-border procurement and distribution partnerships. Headquartered in Tokyo, the company is governed by a board of directors with deep expertise in pharmaceuticals, logistics and healthcare services. Its ADRs trade on the OTC Markets under the symbol MAHLY, providing international investors access to one of Japan’s leading healthcare distribution platforms.

Key Stats

• Today's Range: $16.64 to $16.64
• 50-Day Range: $16.64 to $19.10
• 52-Week Range: $14.60 to $20.35
• Volume: 3 shs
• Average Volume: 833 shs
• Market Capitalization: N/A
• P/E Ratio: 0.17
• Dividend Yield: 137.06%
• Price Target: N/A
• Consensus Rating: N/A

MediPal Stock Analysis - MarketRank™

MediPal scored higher than 42% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for MediPal.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of MediPal is 0.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of MediPal is 0.17, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 24.14.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

MediPal has a short interest ratio ("days to cover") of 0.62, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MediPal has recently decreased by 41.44%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

MediPal pays a meaningful dividend of 1.92%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

MediPal does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of MediPal is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

MediPal has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for MediPal this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MediPal insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.07% of the stock of MediPal is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MAHLY
• CIK: N/A
• Web: www.medipal.co.jp
• Phone: 81-3-3517-5800
• Fax: N/A
• Employees: 12,795
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.17
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A